Quercetin Enhances Angiogenesis and Blood-Spinal Cord Barrier Integrity Post-Spinal Cord Injury: Evidence from PI3K/Akt Pathway Activation

Study Background and Research Question

Spinal cord injury (SCI) is a devastating event with profound neurological consequences and limited therapeutic options. Acute SCI inflicts substantial disruption to the spinal vasculature, causing hemorrhage, thrombosis, and vasospasm that compromise microcirculation. This vascular failure impedes both axonal regeneration and removal of cytotoxic substances, thereby exacerbating functional deficits (source: paper). Equally critical is the integrity of the blood-spinal cord barrier (BSCB), which serves as a selective interface protecting neural tissue from infiltrating immune cells and inflammatory mediators. Disruption of the BSCB following SCI allows for secondary injury cascades, further impeding recovery. The study by Liu et al. (2025) asks whether pharmacological modulation—specifically via quercetin (QCT), a flavonoid with known biological activity—can promote vascular regeneration and BSCB protection by targeting molecular signaling pathways involved in endothelial survival and angiogenesis.

Key Innovation from the Reference Study

The central innovation of Liu et al. (2025) lies in establishing quercetin as a modulator of endogenous repair mechanisms after SCI. Through a combination of in vitro and in vivo experiments, the authors identify the PI3K/Akt pathway as a mechanistic axis through which QCT exerts protective effects on microvascular endothelial cells and the BSCB. Importantly, the work integrates network pharmacology with experimental validation, providing both predictive and empirical evidence for QCT’s role in vascular remodeling post-injury (source: paper).

Methods and Experimental Design Insights

Liu et al. employed a two-pronged experimental framework:

• In vitro ischemia-reperfusion model: Mouse brain microvascular endothelial bEnd.3 cells were subjected to oxygen-glucose deprivation/reperfusion (OGD/R) to simulate SCI-induced vascular insult. QCT’s effects on endothelial survival, tube formation, and migration were quantified. Apoptosis assays, including TUNEL-based detection, were used to measure DNA fragmentation associated with cell death.
• In vivo rat SCI model: Following induction of spinal cord contusion, rats received QCT treatment. Subsequent analyses included behavioral motor function scoring, immunohistochemical assessment of vascular density, BSCB permeability measurements, and histopathological examination for tissue integrity and apoptosis.
• Network pharmacology and pathway validation: Computational predictions identified PI3K/Akt as a principal pathway, which was then validated by Western blotting and functional assays.

This comprehensive design links molecular, cellular, and organismal outcomes, creating a robust translational pipeline.

Protocol Parameters

• assay: TUNEL assay | value_with_unit: cell- and tissue-level apoptosis quantification (semi-quantitative, % TUNEL-positive cells) | applicability: assessment of DNA fragmentation in SCI models | rationale: TUNEL detects 3'-OH DNA ends characteristic of apoptosis, enabling spatial mapping in injured tissue | source_type: paper
• assay: OGD/R exposure | value_with_unit: defined hypoxia/reoxygenation periods (e.g., 4 h deprivation, 24 h reperfusion) | applicability: in vitro simulation of ischemic endothelial injury | rationale: mimics pathophysiological conditions post-SCI | source_type: paper
• assay: Quercetin dose | value_with_unit: 25-100 μM (in vitro), 50 mg/kg (in vivo) | applicability: titration for cytoprotection and functional recovery | rationale: established effective range for endothelial and neural protection | source_type: paper
• assay: BSCB permeability | value_with_unit: Evans Blue extravasation (μg/g tissue) | applicability: functional assessment of barrier integrity | rationale: quantifies leakage of macromolecules across BSCB | source_type: paper
• assay: Tube formation assay | value_with_unit: number/length of capillary-like structures | applicability: angiogenesis assessment | rationale: surrogate for neovascularization capacity | source_type: paper

Core Findings and Why They Matter

Liu et al. report several significant observations:

• QCT enhances endothelial survival and angiogenesis: Both cell viability and tube formation improved in OGD/R-exposed bEnd.3 cells treated with QCT, highlighting reduced apoptosis and increased regenerative capacity (source: paper).
• Reduced DNA fragmentation: TUNEL assay results showed decreased numbers of apoptotic cells in QCT-treated tissues, underscoring its cytoprotective effect (source: paper).
• Preserved BSCB integrity: QCT diminished Evans Blue leakage, correlating with improved histological preservation of the BSCB and reduced secondary inflammatory infiltration.
• Activation of PI3K/Akt signaling: Increased phosphorylation levels of Akt and downstream effectors were observed, confirming the pathway’s involvement in mediating QCT’s protective effects.
• Enhanced functional recovery: Rats receiving QCT exhibited better motor function, which was associated with both vascular and neural tissue preservation.

These findings position QCT as a candidate for modulating post-injury vascular and barrier repair, with mechanistic insights that extend to programmed cell death research and neurovascular protection.

Comparison with Existing Internal Articles

Several internal resources provide context for the technical aspects of apoptosis and DNA fragmentation assays referenced in the Liu et al. study:

• TUNEL Apoptosis Detection Kit (DAB): Precision DNA Fragmentation Assay explores the specificity and reproducibility of TUNEL-based detection in both tissue sections and cultured cells, directly supporting the analytical approach used by Liu et al. for apoptosis quantification.
• Scenario-Driven Solutions with TUNEL Apoptosis Detection offers detailed guidance on assay optimization and interpretation, echoing the study’s emphasis on robust workflow design for DNA fragmentation detection in programmed cell death research.
• Advancing DNA Fragmentation Detection in Apoptosis bridges the use of TUNEL assays with translational neuro-oncology, highlighting the cross-disciplinary relevance of apoptosis detection in central nervous system models.

Together, these resources demonstrate the importance of validated TUNEL assays for quantifying apoptosis and inform best practices for implementing such protocols in SCI and related research domains.

Limitations and Transferability

While the Liu et al. study provides compelling evidence for QCT’s role in vascular and barrier protection, several limitations should be considered:

• Preclinical scope: Results are derived from rodent models and in vitro cell culture, necessitating further validation before clinical translation (source: paper).
• Pathway specificity: Although PI3K/Akt activation is confirmed, the relative contribution of parallel signaling pathways remains to be elucidated.
• Quantitative parameters: The study reports semi-quantitative improvements in apoptosis and barrier integrity but does not fully characterize long-term outcomes or dose responses across diverse SCI severities.

Transferability to other CNS injury models or human tissue will require additional studies and careful protocol adaptation.

Research Support Resources

For researchers aiming to quantify apoptosis or DNA fragmentation in similar SCI or vascular injury models, the TUNEL Apoptosis Detection Kit (DAB) (SKU K2271, APExBIO) provides a validated workflow for sensitive detection in both tissue sections and cultured cells. This kit utilizes TdT enzyme-based labeling and colorimetric detection, supporting reproducible assessment of programmed cell death in translational studies (workflow_recommendation). For detailed technical guidance on TUNEL assay implementation, authoritative scenario-driven and precision assay articles are available through referenced internal resources.